This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
ETF News and Commentary: Archive
Oil ETFs Rally Amid Intensifying U.S.-Venezuela Tension
by Aparajita Dutta
Oil ETFs are rallying as U.S.-Venezuela maritime clashes lift crude prices, adding a geopolitical risk premium.
etfs oil-energy
Best-Performing Sector ETFs of 2025
by Sanghamitra Saha
Metals, shipping and rare earth ETFs like SLVP, BWET and SETM led 2025, and SPY has gained 14.8% YTD despite AI, tariff and rate jitters.
etfs
Bet on These Top-Ranked Healthcare ETFs Before 2025 Ends
by Aparajita Dutta
XLV and similar healthcare ETFs are gaining momentum as strength in biotech, increased AI adoption, and rising defensive demand position the sector for year-end leadership.
etfs medical
M&A: An Overlooked ETF Investing Zone of AI Boom?
by Sanghamitra Saha
AI-driven data-center dealmaking is surging. ETFs like MNA, IAI, KBWB, CHAT offer ways to tap the M&A boom tied to AI infrastructure.
etfs
Cash Growth ETF (BUL) Touches New 52-Week High
by Aparajita Dutta
BUL hits a new 52-week high as strong growth sentiment, tech momentum and a focus on high free cash flow stocks fuel gains.
etfs
Gold Left Behind as Silver Hikes 132% YTD: The ETF Playbook for 2026
by Aparajita Dutta
Silver stole the spotlight in 2025 with a 132% surge, leaving gold behind as supply shortages, green demand and ETF inflows reshape the metals trade.
etfs
Will Santa Claus Rally Set In for 2025? 4 Best ETF Areas to Explore
by Sanghamitra Saha
Santa Rally may lift Wall Street! ETFs like MAGS, XME, JETS & ITA could benefit in Dec -- Jan amid seasonal optimism and market tailwinds.
etfs
Tech ETFs to Buy as Micron Rallies 10% Post Q1 Earnings Beat
by Aparajita Dutta
Micron surged over 10% after a strong Q1 beat, making tech ETFs with high MU exposure an attractive way to tap gains while diversifying risk.
etfs semiconductor tech-stocks
Bank ETFs Shine as US Banking Profit Hits Decade High in Q3
by Aparajita Dutta
Bank ETFs such as FTXO are drawing attention as U.S. banking profits reached a decade high in Q3 2025, setting the stage for continued gains in 2026.
etfs finance
Pharma's $370B Bet on America: The ETF Plays for 2026
by Aparajita Dutta
Pharma ETFs like IHE are gaining traction as drugmakers pledge $370 billion to U.S. projects, fueling a new investment super-cycle heading into 2026.
etfs pharmaceuticals